67 related articles for article (PubMed ID: 8140329)
1. [Antimicrobial activity of human colostrum against enteropathogens. Preliminary study].
Solórzano-Santos F; Castellanos-Cruz RC; Echaniz-Avilés G; Arredondo-García JL
Rev Latinoam Microbiol; 1993; 35(1):1-6. PubMed ID: 8140329
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies on the antimicrobial effects of colostrum and milk from vaccinated and unvaccinated pigs on Escherichia coli.
Nagy LK; Mackenzie T; Bharucha Z
Res Vet Sci; 1976 Sep; 21(2):132-40. PubMed ID: 9677
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors.
Ozgunes I; Erben N; Kiremitci A; Kartal ED; Durmaz G; Colak H; Usluer G; Colak E
Saudi Med J; 2006 May; 27(5):608-12. PubMed ID: 16680246
[TBL] [Abstract][Full Text] [Related]
6. [Antibacterial activity of urine after administration of ofloxacin for 5 days].
Drugeon H; Veyries ML; Levacher M; Garnier M; Aymard G; Giroud JP; Rouveix B
Therapie; 2000; 55(6):691-7. PubMed ID: 11234464
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
8. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
9. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
[TBL] [Abstract][Full Text] [Related]
10. [Serum resistance of Escherichia coli and serum bactericidal activity in chronic pyelonephritis].
Falkenhagen U; Handschuck I; Nimmich W; Zingler G; Naumann G
Z Urol Nephrol; 1984 Nov; 77(11):629-38. PubMed ID: 6395557
[TBL] [Abstract][Full Text] [Related]
11. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
12. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial effects of chitosans and chitooligosaccharides, upon Staphylococcus aureus and Escherichia coli, in food model systems.
Fernandes JC; Tavaria FK; Soares JC; Ramos OS; João Monteiro M; Pintado ME; Xavier Malcata F
Food Microbiol; 2008 Oct; 25(7):922-8. PubMed ID: 18721683
[TBL] [Abstract][Full Text] [Related]
14. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
Alou L; Aguilar L; Sevillano D; Giménez MJ; Cafini F; Valero E; Relaño MT; Prieto J
J Antimicrob Chemother; 2006 Apr; 57(4):714-9. PubMed ID: 16492718
[TBL] [Abstract][Full Text] [Related]
15. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy.
Lautenbach E; Metlay JP; Bilker WB; Edelstein PH; Fishman NO
Clin Infect Dis; 2005 Oct; 41(7):923-9. PubMed ID: 16142655
[TBL] [Abstract][Full Text] [Related]
16. Effect of pasteurization on the bactericidal capacity of human milk.
Silvestre D; Ruiz P; Martínez-Costa C; Plaza A; López MC
J Hum Lact; 2008 Nov; 24(4):371-6. PubMed ID: 18784324
[TBL] [Abstract][Full Text] [Related]
17. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
18. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of antimicrobial agents against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon.
Samaha-Kfoury JN; Kanj SS; Araj GF
Am J Infect Control; 2005 Apr; 33(3):134-6. PubMed ID: 15798666
[TBL] [Abstract][Full Text] [Related]
20. Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea.
Pai H; Choi EH; Lee HJ; Hong JY; Jacoby GA
J Clin Microbiol; 2001 Oct; 39(10):3747-9. PubMed ID: 11574608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
